HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis V Supervie, JG García-Lerma, W Heneine, S Blower Proceedings of the National Academy of Sciences 107 (27), 12381-12386, 2010 | 156 | 2010 |
The undiagnosed HIV epidemic in France and its implications for HIV screening strategies V Supervie, JDA Ndawinz, S Lodi, D Costagliola Aids 28 (12), 1797-1804, 2014 | 121 | 2014 |
Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells B Descours, V Avettand-Fenoel, C Blanc, A Samri, A Mélard, V Supervie, ... Clinical infectious diseases 54 (10), 1495-1503, 2012 | 120 | 2012 |
Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013 A Desgrees-du-Lou, J Pannetier, A Ravalihasy, A Gosselin, V Supervie, ... Eurosurveillance 20 (46), 30065, 2015 | 94 | 2015 |
Revealing geographical and population heterogeneity in HIV incidence, undiagnosed HIV prevalence and time to diagnosis to improve prevention and care: estimates for France L Marty, F Cazein, H Panjo, J Pillonel, D Costagliola, V Supervie, ... Journal of the International AIDS Society 21 (3), e25100, 2018 | 82 | 2018 |
Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance V Supervie, M Barrett, JS Kahn, G Musuka, TL Moeti, L Busang, S Blower Scientific reports 1 (1), 185, 2011 | 78 | 2011 |
The unrecognised French BSE epidemic V Supervie, D Costagliola Veterinary Research 35 (3), 349-362, 2004 | 74 | 2004 |
New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France JDA Ndawinz, D Costagliola, V Supervie Aids 25 (15), 1905-1913, 2011 | 73 | 2011 |
The human immunodeficiency virus continuum of care in European Union countries in 2013: data and challenges A Gourlay, T Noori, A Pharris, M Axelsson, D Costagliola, S Cowan, ... Clinical Infectious Diseases 64 (12), 1644-1656, 2017 | 70 | 2017 |
Looking beyond the cascade of HIV care to end the AIDS epidemic: estimation of the time interval from HIV infection to viral suppression V Supervie, L Marty, JM Lacombe, R Dray-Spira, D Costagliola, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (3), 348-355, 2016 | 56 | 2016 |
Predicting the future of XDR tuberculosis S Blower, V Supervie The Lancet Infectious Diseases 7 (7), 443, 2007 | 55 | 2007 |
HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV Working Group on Estimation of HIV Prevalence in Europe Aids 25 (8), 1017-1023, 2011 | 53 | 2011 |
Heterosexual risk of HIV transmission per sexual act under combined antiretroviral therapy: systematic review and bayesian modeling V Supervie, JP Viard, D Costagliola, R Breban Clinical Infectious Diseases 59 (1), 115-122, 2014 | 52 | 2014 |
Assessing the impact of mass rape on the incidence of HIV in conflict-affected countries V Supervie, Y Halima, S Blower Aids 24 (18), 2841-2847, 2010 | 47 | 2010 |
Summarizing the results and methods of the 2019 Joint United Nations Programme on HIV/AIDS HIV estimates KK Case, LF Johnson, M Mahy, K Marsh, V Supervie, JW Eaton Aids 33, S197-S201, 2019 | 43 | 2019 |
Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis JDA Ndawinz, B Chaix, S Koulla-Shiro, E Delaporte, B Okouda, A Abanda, ... Journal of Antimicrobial Chemotherapy 68 (6), 1388-1399, 2013 | 40 | 2013 |
HIV testing within general practices in Europe: a mixed-methods systematic review J Deblonde, D Van Beckhoven, J Loos, N Boffin, A Sasse, C Nöstlinger, ... BMC Public Health 18, 1-15, 2018 | 37 | 2018 |
Substantial heterogeneity in progress toward reaching the 90-90-90 HIV target in the who European region K Porter, A Gourlay, K Attawell, D Hales, V Supervie, G Touloumi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 79 (1), 28-37, 2018 | 37 | 2018 |
Is there any evidence that syphilis epidemics cycle? R Breban, V Supervie, JT Okano, R Vardavas, S Blower The Lancet infectious diseases 8 (9), 577-581, 2008 | 31 | 2008 |
Monitoring the HIV continuum of care in key populations across Europe and Central Asia AE Brown, K Attawell, D Hales, BD Rice, A Pharris, V Supervie, ... HIV medicine 19 (7), 431-439, 2018 | 25 | 2018 |